Industry Research Reports

Home > Reports > Chemical & Material > Mesalazine API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Mesalazine API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Chemical & Material

Published: 2024-01-04

Pages: 143 Pages

Report ld: 2428047

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally.

The global market for Mesalazine API was estimated to be worth US$ 161.9 million in 2023 and is forecast to a readjusted size of US$ 224 million by 2030 with a CAGR of 3.7% during the forecast period 2024-2030

Mesalazine API Market Size

M= millions and B=billions

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Mesalazine API, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Mesalazine API by region & country, by Type, and by Application.

The Mesalazine API market size, estimations, and forecasts are provided in terms of sales volume (Tons) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Mesalazine API.

Market Segmentation

Report Metric
Details
Report Title
Mesalazine API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 224 million
CAGR(2024-2030)
3.7%
Market Size Available for Years
2019-2030
Global Mesalazine API Companies Covered
PharmaZell, Syntese A/S, Cambrex Corporation, Divis Laboratories, Chemi SpA, Ipca Laboratories, Hangzhou Brother, Lianyungang Fengheng Biopharm, Lasa Loboratory, Corden Pharma Bergamo, Erregierre SpA, CTX Lifescience, Ishita Active Pharma Ingredients, YC Biotech (Jiangsu), Xinxiang Tianfeng Fine Chemical
Global Mesalazine API Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Mesalazine API Market, Segment by Type
Above 97 %

Above 98 %

Above 99 %
Global Mesalazine API Market, Segment by Application
Tablets

Capsules

Granule

Suppository

Enema

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Mesalazine API manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Mesalazine API in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Mesalazine API in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Mesalazine API Product Introduction
    1.2 Global Mesalazine API Market Size Forecast
        1.2.1 Global Mesalazine API Sales Value (2019-2030)
        1.2.2 Global Mesalazine API Sales Volume (2019-2030)
        1.2.3 Global Mesalazine API Sales Price (2019-2030)
    1.3 Mesalazine API Market Trends & Drivers
        1.3.1 Mesalazine API Industry Trends
        1.3.2 Mesalazine API Market Drivers & Opportunity
        1.3.3 Mesalazine API Market Challenges
        1.3.4 Mesalazine API Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Mesalazine API Players Revenue Ranking (2023)
    2.2 Global Mesalazine API Revenue by Company (2019-2024)
    2.3 Global Mesalazine API Players Sales Volume Ranking (2023)
    2.4 Global Mesalazine API Sales Volume by Company Players (2019-2024)
    2.5 Global Mesalazine API Average Price by Company (2019-2024)
    2.6 Key Manufacturers Mesalazine API Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Mesalazine API Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Mesalazine API
    2.9 Mesalazine API Market Competitive Analysis
        2.9.1 Mesalazine API Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Mesalazine API Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalazine API as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Above 97 %
        3.1.2 Above 98 %
        3.1.3 Above 99 %
    3.2 Global Mesalazine API Sales Value by Type
        3.2.1 Global Mesalazine API Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Mesalazine API Sales Value, by Type (2019-2030)
        3.2.3 Global Mesalazine API Sales Value, by Type (%) (2019-2030)
    3.3 Global Mesalazine API Sales Volume by Type
        3.3.1 Global Mesalazine API Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Mesalazine API Sales Volume, by Type (2019-2030)
        3.3.3 Global Mesalazine API Sales Volume, by Type (%) (2019-2030)
    3.4 Global Mesalazine API Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Tablets
        4.1.2 Capsules
        4.1.3 Granule
        4.1.4 Suppository
        4.1.5 Enema
        4.1.6 Others
    4.2 Global Mesalazine API Sales Value by Application
        4.2.1 Global Mesalazine API Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Mesalazine API Sales Value, by Application (2019-2030)
        4.2.3 Global Mesalazine API Sales Value, by Application (%) (2019-2030)
    4.3 Global Mesalazine API Sales Volume by Application
        4.3.1 Global Mesalazine API Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Mesalazine API Sales Volume, by Application (2019-2030)
        4.3.3 Global Mesalazine API Sales Volume, by Application (%) (2019-2030)
    4.4 Global Mesalazine API Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Mesalazine API Sales Value by Region
        5.1.1 Global Mesalazine API Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Mesalazine API Sales Value by Region (2019-2024)
        5.1.3 Global Mesalazine API Sales Value by Region (2025-2030)
        5.1.4 Global Mesalazine API Sales Value by Region (%), (2019-2030)
    5.2 Global Mesalazine API Sales Volume by Region
        5.2.1 Global Mesalazine API Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Mesalazine API Sales Volume by Region (2019-2024)
        5.2.3 Global Mesalazine API Sales Volume by Region (2025-2030)
        5.2.4 Global Mesalazine API Sales Volume by Region (%), (2019-2030)
    5.3 Global Mesalazine API Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Mesalazine API Sales Value, 2019-2030
        5.4.2 North America Mesalazine API Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Mesalazine API Sales Value, 2019-2030
        5.5.2 Europe Mesalazine API Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Mesalazine API Sales Value, 2019-2030
        5.6.2 Asia Pacific Mesalazine API Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Mesalazine API Sales Value, 2019-2030
        5.7.2 South America Mesalazine API Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Mesalazine API Sales Value, 2019-2030
        5.8.2 Middle East & Africa Mesalazine API Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Mesalazine API Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Mesalazine API Sales Value
        6.2.1 Key Countries/Regions Mesalazine API Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Mesalazine API Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Mesalazine API Sales Value, 2019-2030
        6.3.2 United States Mesalazine API Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Mesalazine API Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Mesalazine API Sales Value, 2019-2030
        6.4.2 Europe Mesalazine API Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Mesalazine API Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Mesalazine API Sales Value, 2019-2030
        6.5.2 China Mesalazine API Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Mesalazine API Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Mesalazine API Sales Value, 2019-2030
        6.6.2 Japan Mesalazine API Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Mesalazine API Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Mesalazine API Sales Value, 2019-2030
        6.7.2 South Korea Mesalazine API Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Mesalazine API Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Mesalazine API Sales Value, 2019-2030
        6.8.2 Southeast Asia Mesalazine API Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Mesalazine API Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Mesalazine API Sales Value, 2019-2030
        6.9.2 India Mesalazine API Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Mesalazine API Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 PharmaZell
        7.1.1 PharmaZell Company Information
        7.1.2 PharmaZell Introduction and Business Overview
        7.1.3 PharmaZell Mesalazine API Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 PharmaZell Mesalazine API Product Offerings
        7.1.5 PharmaZell Recent Development
    7.2 Syntese A/S
        7.2.1 Syntese A/S Company Information
        7.2.2 Syntese A/S Introduction and Business Overview
        7.2.3 Syntese A/S Mesalazine API Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Syntese A/S Mesalazine API Product Offerings
        7.2.5 Syntese A/S Recent Development
    7.3 Cambrex Corporation
        7.3.1 Cambrex Corporation Company Information
        7.3.2 Cambrex Corporation Introduction and Business Overview
        7.3.3 Cambrex Corporation Mesalazine API Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Cambrex Corporation Mesalazine API Product Offerings
        7.3.5 Cambrex Corporation Recent Development
    7.4 Divis Laboratories
        7.4.1 Divis Laboratories Company Information
        7.4.2 Divis Laboratories Introduction and Business Overview
        7.4.3 Divis Laboratories Mesalazine API Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Divis Laboratories Mesalazine API Product Offerings
        7.4.5 Divis Laboratories Recent Development
    7.5 Chemi SpA
        7.5.1 Chemi SpA Company Information
        7.5.2 Chemi SpA Introduction and Business Overview
        7.5.3 Chemi SpA Mesalazine API Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Chemi SpA Mesalazine API Product Offerings
        7.5.5 Chemi SpA Recent Development
    7.6 Ipca Laboratories
        7.6.1 Ipca Laboratories Company Information
        7.6.2 Ipca Laboratories Introduction and Business Overview
        7.6.3 Ipca Laboratories Mesalazine API Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Ipca Laboratories Mesalazine API Product Offerings
        7.6.5 Ipca Laboratories Recent Development
    7.7 Hangzhou Brother
        7.7.1 Hangzhou Brother Company Information
        7.7.2 Hangzhou Brother Introduction and Business Overview
        7.7.3 Hangzhou Brother Mesalazine API Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Hangzhou Brother Mesalazine API Product Offerings
        7.7.5 Hangzhou Brother Recent Development
    7.8 Lianyungang Fengheng Biopharm
        7.8.1 Lianyungang Fengheng Biopharm Company Information
        7.8.2 Lianyungang Fengheng Biopharm Introduction and Business Overview
        7.8.3 Lianyungang Fengheng Biopharm Mesalazine API Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Lianyungang Fengheng Biopharm Mesalazine API Product Offerings
        7.8.5 Lianyungang Fengheng Biopharm Recent Development
    7.9 Lasa Loboratory
        7.9.1 Lasa Loboratory Company Information
        7.9.2 Lasa Loboratory Introduction and Business Overview
        7.9.3 Lasa Loboratory Mesalazine API Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Lasa Loboratory Mesalazine API Product Offerings
        7.9.5 Lasa Loboratory Recent Development
    7.10 Corden Pharma Bergamo
        7.10.1 Corden Pharma Bergamo Company Information
        7.10.2 Corden Pharma Bergamo Introduction and Business Overview
        7.10.3 Corden Pharma Bergamo Mesalazine API Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Corden Pharma Bergamo Mesalazine API Product Offerings
        7.10.5 Corden Pharma Bergamo Recent Development
    7.11 Erregierre SpA
        7.11.1 Erregierre SpA Company Information
        7.11.2 Erregierre SpA Introduction and Business Overview
        7.11.3 Erregierre SpA Mesalazine API Sales, Revenue and Gross Margin (2019-2024)
        7.11.4 Erregierre SpA Mesalazine API Product Offerings
        7.11.5 Erregierre SpA Recent Development
    7.12 CTX Lifescience
        7.12.1 CTX Lifescience Company Information
        7.12.2 CTX Lifescience Introduction and Business Overview
        7.12.3 CTX Lifescience Mesalazine API Sales, Revenue and Gross Margin (2019-2024)
        7.12.4 CTX Lifescience Mesalazine API Product Offerings
        7.12.5 CTX Lifescience Recent Development
    7.13 Ishita Active Pharma Ingredients
        7.13.1 Ishita Active Pharma Ingredients Company Information
        7.13.2 Ishita Active Pharma Ingredients Introduction and Business Overview
        7.13.3 Ishita Active Pharma Ingredients Mesalazine API Sales, Revenue and Gross Margin (2019-2024)
        7.13.4 Ishita Active Pharma Ingredients Mesalazine API Product Offerings
        7.13.5 Ishita Active Pharma Ingredients Recent Development
    7.14 YC Biotech (Jiangsu)
        7.14.1 YC Biotech (Jiangsu) Company Information
        7.14.2 YC Biotech (Jiangsu) Introduction and Business Overview
        7.14.3 YC Biotech (Jiangsu) Mesalazine API Sales, Revenue and Gross Margin (2019-2024)
        7.14.4 YC Biotech (Jiangsu) Mesalazine API Product Offerings
        7.14.5 YC Biotech (Jiangsu) Recent Development
    7.15 Xinxiang Tianfeng Fine Chemical
        7.15.1 Xinxiang Tianfeng Fine Chemical Company Information
        7.15.2 Xinxiang Tianfeng Fine Chemical Introduction and Business Overview
        7.15.3 Xinxiang Tianfeng Fine Chemical Mesalazine API Sales, Revenue and Gross Margin (2019-2024)
        7.15.4 Xinxiang Tianfeng Fine Chemical Mesalazine API Product Offerings
        7.15.5 Xinxiang Tianfeng Fine Chemical Recent Development

 8 Industry Chain Analysis
    8.1 Mesalazine API Industrial Chain
    8.2 Mesalazine API Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Mesalazine API Sales Model
        8.5.2 Sales Channel
        8.5.3 Mesalazine API Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Mesalazine API Market Trends
    Table 2. Mesalazine API Market Drivers & Opportunity
    Table 3. Mesalazine API Market Challenges
    Table 4. Mesalazine API Market Restraints
    Table 5. Global Mesalazine API Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Mesalazine API Revenue Market Share by Company (2019-2024)
    Table 7. Global Mesalazine API Sales Volume by Company (2019-2024) & (Tons)
    Table 8. Global Mesalazine API Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Mesalazine API Price by Company (2019-2024) & (US$/Ton)
    Table 10. Key Manufacturers Mesalazine API Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Mesalazine API Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Mesalazine API
    Table 13. Global Mesalazine API Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Mesalazine API as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Mesalazine API Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Mesalazine API Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Mesalazine API Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Mesalazine API Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Mesalazine API Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Mesalazine API Sales Volume by Type: 2019 VS 2023 VS 2030 (Tons)
    Table 22. Global Mesalazine API Sales Volume by Type (2019-2024) & (Tons)
    Table 23. Global Mesalazine API Sales Volume by Type (2025-2030) & (Tons)
    Table 24. Global Mesalazine API Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Mesalazine API Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Mesalazine API Price by Type (2019-2024) & (US$/Ton)
    Table 27. Global Mesalazine API Price by Type (2025-2030) & (US$/Ton)
    Table 28. Global Mesalazine API Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Mesalazine API Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Mesalazine API Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Mesalazine API Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Mesalazine API Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Mesalazine API Sales Volume by Application: 2019 VS 2023 VS 2030 (Tons)
    Table 34. Global Mesalazine API Sales Volume by Application (2019-2024) & (Tons)
    Table 35. Global Mesalazine API Sales Volume by Application (2025-2030) & (Tons)
    Table 36. Global Mesalazine API Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Mesalazine API Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Mesalazine API Price by Application (2019-2024) & (US$/Ton)
    Table 39. Global Mesalazine API Price by Application (2025-2030) & (US$/Ton)
    Table 40. Global Mesalazine API Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Mesalazine API Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Mesalazine API Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Mesalazine API Sales Value by Region (2019-2024) & (%)
    Table 44. Global Mesalazine API Sales Value by Region (2025-2030) & (%)
    Table 45. Global Mesalazine API Sales Volume by Region (Tons): 2019 VS 2023 VS 2030
    Table 46. Global Mesalazine API Sales Volume by Region (2019-2024) & (Tons)
    Table 47. Global Mesalazine API Sales Volume by Region (2025-2030) & (Tons)
    Table 48. Global Mesalazine API Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Mesalazine API Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Mesalazine API Average Price by Region (2019-2024) & (US$/Ton)
    Table 51. Global Mesalazine API Average Price by Region (2025-2030) & (US$/Ton)
    Table 52. Key Countries/Regions Mesalazine API Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Mesalazine API Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Mesalazine API Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Mesalazine API Sales Volume, (2019-2024) & (Tons)
    Table 56. Key Countries/Regions Mesalazine API Sales Volume, (2025-2030) & (Tons)
    Table 57. PharmaZell Company Information
    Table 58. PharmaZell Introduction and Business Overview
    Table 59. PharmaZell Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 60. PharmaZell Mesalazine API Product Offerings
    Table 61. PharmaZell Recent Development
    Table 62. Syntese A/S Company Information
    Table 63. Syntese A/S Introduction and Business Overview
    Table 64. Syntese A/S Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 65. Syntese A/S Mesalazine API Product Offerings
    Table 66. Syntese A/S Recent Development
    Table 67. Cambrex Corporation Company Information
    Table 68. Cambrex Corporation Introduction and Business Overview
    Table 69. Cambrex Corporation Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 70. Cambrex Corporation Mesalazine API Product Offerings
    Table 71. Cambrex Corporation Recent Development
    Table 72. Divis Laboratories Company Information
    Table 73. Divis Laboratories Introduction and Business Overview
    Table 74. Divis Laboratories Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 75. Divis Laboratories Mesalazine API Product Offerings
    Table 76. Divis Laboratories Recent Development
    Table 77. Chemi SpA Company Information
    Table 78. Chemi SpA Introduction and Business Overview
    Table 79. Chemi SpA Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 80. Chemi SpA Mesalazine API Product Offerings
    Table 81. Chemi SpA Recent Development
    Table 82. Ipca Laboratories Company Information
    Table 83. Ipca Laboratories Introduction and Business Overview
    Table 84. Ipca Laboratories Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 85. Ipca Laboratories Mesalazine API Product Offerings
    Table 86. Ipca Laboratories Recent Development
    Table 87. Hangzhou Brother Company Information
    Table 88. Hangzhou Brother Introduction and Business Overview
    Table 89. Hangzhou Brother Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 90. Hangzhou Brother Mesalazine API Product Offerings
    Table 91. Hangzhou Brother Recent Development
    Table 92. Lianyungang Fengheng Biopharm Company Information
    Table 93. Lianyungang Fengheng Biopharm Introduction and Business Overview
    Table 94. Lianyungang Fengheng Biopharm Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 95. Lianyungang Fengheng Biopharm Mesalazine API Product Offerings
    Table 96. Lianyungang Fengheng Biopharm Recent Development
    Table 97. Lasa Loboratory Company Information
    Table 98. Lasa Loboratory Introduction and Business Overview
    Table 99. Lasa Loboratory Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 100. Lasa Loboratory Mesalazine API Product Offerings
    Table 101. Lasa Loboratory Recent Development
    Table 102. Corden Pharma Bergamo Company Information
    Table 103. Corden Pharma Bergamo Introduction and Business Overview
    Table 104. Corden Pharma Bergamo Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 105. Corden Pharma Bergamo Mesalazine API Product Offerings
    Table 106. Corden Pharma Bergamo Recent Development
    Table 107. Erregierre SpA Company Information
    Table 108. Erregierre SpA Introduction and Business Overview
    Table 109. Erregierre SpA Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 110. Erregierre SpA Mesalazine API Product Offerings
    Table 111. Erregierre SpA Recent Development
    Table 112. CTX Lifescience Company Information
    Table 113. CTX Lifescience Introduction and Business Overview
    Table 114. CTX Lifescience Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 115. CTX Lifescience Mesalazine API Product Offerings
    Table 116. CTX Lifescience Recent Development
    Table 117. Ishita Active Pharma Ingredients Company Information
    Table 118. Ishita Active Pharma Ingredients Introduction and Business Overview
    Table 119. Ishita Active Pharma Ingredients Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 120. Ishita Active Pharma Ingredients Mesalazine API Product Offerings
    Table 121. Ishita Active Pharma Ingredients Recent Development
    Table 122. YC Biotech (Jiangsu) Company Information
    Table 123. YC Biotech (Jiangsu) Introduction and Business Overview
    Table 124. YC Biotech (Jiangsu) Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 125. YC Biotech (Jiangsu) Mesalazine API Product Offerings
    Table 126. YC Biotech (Jiangsu) Recent Development
    Table 127. Xinxiang Tianfeng Fine Chemical Company Information
    Table 128. Xinxiang Tianfeng Fine Chemical Introduction and Business Overview
    Table 129. Xinxiang Tianfeng Fine Chemical Mesalazine API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
    Table 130. Xinxiang Tianfeng Fine Chemical Mesalazine API Product Offerings
    Table 131. Xinxiang Tianfeng Fine Chemical Recent Development
    Table 132. Key Raw Materials Lists
    Table 133. Raw Materials Key Suppliers Lists
    Table 134. Mesalazine API Downstream Customers
    Table 135. Mesalazine API Distributors List
    Table 136. Research Programs/Design for This Report
    Table 137. Key Data Information from Secondary Sources
    Table 138. Key Data Information from Primary Sources
List of Figures
    Figure 1. Mesalazine API Product Picture
    Figure 2. Global Mesalazine API Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Mesalazine API Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Mesalazine API Sales Volume (2019-2030) & (Tons)
    Figure 5. Global Mesalazine API Sales Price (2019-2030) & (US$/Ton)
    Figure 6. Mesalazine API Report Years Considered
    Figure 7. Global Mesalazine API Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Mesalazine API Players Sales Volume Ranking (2023) & (Tons)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Mesalazine API Revenue in 2023
    Figure 10. Mesalazine API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Above 97 % Picture
    Figure 12. Above 98 % Picture
    Figure 13. Above 99 % Picture
    Figure 14. Global Mesalazine API Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Mesalazine API Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Mesalazine API Sales Volume by Type (2019 VS 2023 VS 2030) & (Tons)
    Figure 17. Global Mesalazine API Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Mesalazine API Price by Type (2019-2030) & (US$/Ton)
    Figure 19. Product Picture of Tablets
    Figure 20. Product Picture of Capsules
    Figure 21. Product Picture of Granule
    Figure 22. Product Picture of Suppository
    Figure 23. Product Picture of Enema
    Figure 24. Product Picture of Others
    Figure 25. Global Mesalazine API Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 26. Global Mesalazine API Sales Value Market Share by Application, 2023 & 2030
    Figure 27. Global Mesalazine API Sales Volume by Application (2019 VS 2023 VS 2030) & (Tons)
    Figure 28. Global Mesalazine API Sales Volume Market Share by Application, 2023 & 2030
    Figure 29. Global Mesalazine API Price by Application (2019-2030) & (US$/Ton)
    Figure 30. North America Mesalazine API Sales Value (2019-2030) & (US$ Million)
    Figure 31. North America Mesalazine API Sales Value by Country (%), 2023 VS 2030
    Figure 32. Europe Mesalazine API Sales Value (2019-2030) & (US$ Million)
    Figure 33. Europe Mesalazine API Sales Value by Country (%), 2023 VS 2030
    Figure 34. Asia Pacific Mesalazine API Sales Value (2019-2030) & (US$ Million)
    Figure 35. Asia Pacific Mesalazine API Sales Value by Country (%), 2023 VS 2030
    Figure 36. South America Mesalazine API Sales Value (2019-2030) & (US$ Million)
    Figure 37. South America Mesalazine API Sales Value by Country (%), 2023 VS 2030
    Figure 38. Middle East & Africa Mesalazine API Sales Value (2019-2030) & (US$ Million)
    Figure 39. Middle East & Africa Mesalazine API Sales Value by Country (%), 2023 VS 2030
    Figure 40. Key Countries/Regions Mesalazine API Sales Value (%), (2019-2030)
    Figure 41. Key Countries/Regions Mesalazine API Sales Volume (%), (2019-2030)
    Figure 42. United States Mesalazine API Sales Value, (2019-2030) & (US$ Million)
    Figure 43. United States Mesalazine API Sales Value by Type (%), 2023 VS 2030
    Figure 44. United States Mesalazine API Sales Value by Application (%), 2023 VS 2030
    Figure 45. Europe Mesalazine API Sales Value, (2019-2030) & (US$ Million)
    Figure 46. Europe Mesalazine API Sales Value by Type (%), 2023 VS 2030
    Figure 47. Europe Mesalazine API Sales Value by Application (%), 2023 VS 2030
    Figure 48. China Mesalazine API Sales Value, (2019-2030) & (US$ Million)
    Figure 49. China Mesalazine API Sales Value by Type (%), 2023 VS 2030
    Figure 50. China Mesalazine API Sales Value by Application (%), 2023 VS 2030
    Figure 51. Japan Mesalazine API Sales Value, (2019-2030) & (US$ Million)
    Figure 52. Japan Mesalazine API Sales Value by Type (%), 2023 VS 2030
    Figure 53. Japan Mesalazine API Sales Value by Application (%), 2023 VS 2030
    Figure 54. South Korea Mesalazine API Sales Value, (2019-2030) & (US$ Million)
    Figure 55. South Korea Mesalazine API Sales Value by Type (%), 2023 VS 2030
    Figure 56. South Korea Mesalazine API Sales Value by Application (%), 2023 VS 2030
    Figure 57. Southeast Asia Mesalazine API Sales Value, (2019-2030) & (US$ Million)
    Figure 58. Southeast Asia Mesalazine API Sales Value by Type (%), 2023 VS 2030
    Figure 59. Southeast Asia Mesalazine API Sales Value by Application (%), 2023 VS 2030
    Figure 60. India Mesalazine API Sales Value, (2019-2030) & (US$ Million)
    Figure 61. India Mesalazine API Sales Value by Type (%), 2023 VS 2030
    Figure 62. India Mesalazine API Sales Value by Application (%), 2023 VS 2030
    Figure 63. Mesalazine API Industrial Chain
    Figure 64. Mesalazine API Manufacturing Cost Structure
    Figure 65. Channels of Distribution (Direct Sales, and Distribution)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed

Description

Mesalazine also known as mesalamine, or 5-aminosalicylic acid (5-ASA), is a medication used to treat inflammatory bowel disease, including ulcerative colitis and Crohn's disease. It is generally used for mildly to moderately severe disease. It is taken by mouth or rectally.

The global market for Mesalazine API was estimated to be worth US$ 161.9 million in 2023 and is forecast to a readjusted size of US$ 224 million by 2030 with a CAGR of 3.7% during the forecast period 2024-2030

Market Segmentation